104944-23-2

Basic information

• Product Name: Phosphonic acid, [(S)-hydroxyphenylmethyl]-
• CAS NO: 104944-23-2
• Molecular Formula: C7H9O4P
• Molecular Weight: 188.12
• Mol File: 104944-23-2.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: Phosphonic acid, [(S)-hydroxyphenylmethyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Phosphonic acid, [(S)-hydroxyphenylmethyl]-(104944-23-2)
• EPA Substance Registry System: Phosphonic acid, [(S)-hydroxyphenylmethyl]-(104944-23-2)

Safety Data

• Hazardous Substances Data: 104944-23-2(Hazardous Substances Data)

Upstream product

• 3277-27-8 diethyl benzoylphosphonate 
• 1045892-61-2 C₁₁H₁₁F₆O₄P 
• 100-52-7 benzaldehyde 
• 20386-43-0 (hydroxy-phenyl-methyl)-phosphonic acid diisopropyl ester 
• 18406-56-9 Bis(trimethylsilyl) benzylphosphonate 
• 1499-19-0 benzylphosphonic dichloride 
• 1080-32-6 O,O-diethyl benzylphosphonate 
• 889103-61-1 di-(1R,2S,5R)-menthyl (S)-1-phenyl-1-hydroxymethylphosphonate 
• 85166-92-3 diethyl [(S)-hydroxy(phenyl)methyl]phosphonate 
• 147731-05-3 diisopropyl (S)-(-)-[hydroxy(phenyl)methyl]phosphonate 
• 74038-34-9 diallyl benzylphosphonate 
• 741292-48-8 di-(1R,2S,5R)-menthyl benzoylphosphonate 
• 536739-06-7 diallyl (S)-α-hydroxybenzylphosphonate 

Downstream Products

• 97995-93-2 dimethyl (S)-phenyl(hydroxy)methylphosphonate 
• 104944-34-5 (R)-2-tert-Butoxycarbonylamino-propionic acid (R)-(bis-benzhydryloxy-phosphoryl)-phenyl-methyl ester 
• 104944-40-3 (R)-2-Amino-3-methyl-butyric acid (R)-phenyl-phosphono-methyl ester 
• 104944-39-0 (R)-2-Amino-propionic acid (R)-phenyl-phosphono-methyl ester 
• 104944-35-6 (R)-2-tert-Butoxycarbonylamino-3-methyl-butyric acid (R)-(bis-benzhydryloxy-phosphoryl)-phenyl-methyl ester 
• 89865-26-9 (Hydroxy-phenyl-methyl)-phosphonic acid dibenzhydryl ester 

Relevant articles and documents

New method for the asymmetric reduction of ketophosphonates

Chiral reducing reactants were prepared from lithium, sodium, or tetrabutylammonium borohydrides and (S)- or (R)-tartaric acids. Copyright Taylor & Francis Group, LLC.

Substrate-Based fragment identification for the development of selective, nonpeptidic inhibitors of striatal-enriched protein tyrosine phosphatase

High levels of striatal-enriched protein tyrosine phosphatase (STEP) activity are observed in a number of neuropsychiatric disorders such as Alzheimer's disease. Overexpression of STEP results in the dephosphorylation and inactivation of many key neuronal

Synthesis of optically active hydroxyphosphonates

The reduction of dimenthyl ketophosphonates with sodium borohydride involves asymmetric induction at the a-carbon atom, resulting in a small excess of the (R)-enantiomer of the a-hydroxyphosphonate formed. A higher ee purity was achieved if the reduction